Please sign in to follow a disease.
Camurus AB
Clinical trials sponsored by Camurus AB, explained in plain language.
Swedish pharmaceutical company developing long-acting drug delivery products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot every 2 weeks could control tumor growth in gut cancers Results expected Nov 2026 (estimated)